Aspergillus colonisation and antifungal immunity in cystic fibrosis patients

Adilia Warris (Corresponding Author), Amelia Bercusson, Darius Armstrong-James

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Cystic fibrosis (CF), caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, is the most common inherited life-limiting disease in North European people affecting 90,000 people worldwide. Progressive lung damage caused by recurrent infection and chronic airway inflammation is the major determinant of survival with a median age at death of 29 years. Approximately 60% of CF patients are infected with Aspergillus fumigatus, a ubiquitous environmental fungus, and its presence has been associated with accelerated lung function decline. Half of the patients infected with Aspergillus are <18 years of age. Yet, time of acquisition of this fungus and determinants of CF-related Aspergillus disease severity and progression are not known. CFTR expression has been demonstrated in cells of the innate and adaptive immune system and has shown to be critical for normal function. Research delineating the role of CFTR-deficient phagocytes in Aspergillus persistence and infection in the CF lung, has only recently received attention. In this concise review we aim to present the current understanding with respect to when people with CF acquire infection with A. fumigatus and antifungal immune responses by CF immune cells.
Original languageEnglish
Pages (from-to)S118-S126
Number of pages9
JournalMedical Mycology
Volume57
Issue numberSuppl. 2
Early online date28 Feb 2019
DOIs
Publication statusPublished - 1 Apr 2019

Fingerprint

Aspergillus
Cystic Fibrosis
Immunity
Aspergillus fumigatus
Lung
Fungi
Regulator Genes
Phagocytes
Infection
Disease Progression
Inflammation
Mutation
Survival

Keywords

  • aspergillosis
  • aspergillus fumigatus
  • cystic fibrosis
  • colonisation
  • innate immunity
  • colonization
  • Aspergillus fumigatus

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Warris, A., Bercusson, A., & Armstrong-James, D. (2019). Aspergillus colonisation and antifungal immunity in cystic fibrosis patients. Medical Mycology, 57(Suppl. 2), S118-S126. https://doi.org/10.1093/mmy/myy074

Aspergillus colonisation and antifungal immunity in cystic fibrosis patients. / Warris, Adilia (Corresponding Author); Bercusson, Amelia; Armstrong-James, Darius.

In: Medical Mycology, Vol. 57, No. Suppl. 2, 01.04.2019, p. S118-S126.

Research output: Contribution to journalReview article

Warris, A, Bercusson, A & Armstrong-James, D 2019, 'Aspergillus colonisation and antifungal immunity in cystic fibrosis patients', Medical Mycology, vol. 57, no. Suppl. 2, pp. S118-S126. https://doi.org/10.1093/mmy/myy074
Warris, Adilia ; Bercusson, Amelia ; Armstrong-James, Darius. / Aspergillus colonisation and antifungal immunity in cystic fibrosis patients. In: Medical Mycology. 2019 ; Vol. 57, No. Suppl. 2. pp. S118-S126.
@article{4e79b7e3202848e2a16677b65dad1174,
title = "Aspergillus colonisation and antifungal immunity in cystic fibrosis patients",
abstract = "Cystic fibrosis (CF), caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, is the most common inherited life-limiting disease in North European people affecting 90,000 people worldwide. Progressive lung damage caused by recurrent infection and chronic airway inflammation is the major determinant of survival with a median age at death of 29 years. Approximately 60{\%} of CF patients are infected with Aspergillus fumigatus, a ubiquitous environmental fungus, and its presence has been associated with accelerated lung function decline. Half of the patients infected with Aspergillus are <18 years of age. Yet, time of acquisition of this fungus and determinants of CF-related Aspergillus disease severity and progression are not known. CFTR expression has been demonstrated in cells of the innate and adaptive immune system and has shown to be critical for normal function. Research delineating the role of CFTR-deficient phagocytes in Aspergillus persistence and infection in the CF lung, has only recently received attention. In this concise review we aim to present the current understanding with respect to when people with CF acquire infection with A. fumigatus and antifungal immune responses by CF immune cells.",
keywords = "aspergillosis, aspergillus fumigatus, cystic fibrosis, colonisation, innate immunity, colonization, Aspergillus fumigatus",
author = "Adilia Warris and Amelia Bercusson and Darius Armstrong-James",
note = "Invited Review. AB and AW are supported by the Wellcome Trust Strategic Award in Medical Mycology and Fungal Immunology (grant 097377). AW is supported by the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.",
year = "2019",
month = "4",
day = "1",
doi = "10.1093/mmy/myy074",
language = "English",
volume = "57",
pages = "S118--S126",
journal = "Medical Mycology",
issn = "1369-3786",
publisher = "Informa Healthcare",
number = "Suppl. 2",

}

TY - JOUR

T1 - Aspergillus colonisation and antifungal immunity in cystic fibrosis patients

AU - Warris, Adilia

AU - Bercusson, Amelia

AU - Armstrong-James, Darius

N1 - Invited Review. AB and AW are supported by the Wellcome Trust Strategic Award in Medical Mycology and Fungal Immunology (grant 097377). AW is supported by the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Cystic fibrosis (CF), caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, is the most common inherited life-limiting disease in North European people affecting 90,000 people worldwide. Progressive lung damage caused by recurrent infection and chronic airway inflammation is the major determinant of survival with a median age at death of 29 years. Approximately 60% of CF patients are infected with Aspergillus fumigatus, a ubiquitous environmental fungus, and its presence has been associated with accelerated lung function decline. Half of the patients infected with Aspergillus are <18 years of age. Yet, time of acquisition of this fungus and determinants of CF-related Aspergillus disease severity and progression are not known. CFTR expression has been demonstrated in cells of the innate and adaptive immune system and has shown to be critical for normal function. Research delineating the role of CFTR-deficient phagocytes in Aspergillus persistence and infection in the CF lung, has only recently received attention. In this concise review we aim to present the current understanding with respect to when people with CF acquire infection with A. fumigatus and antifungal immune responses by CF immune cells.

AB - Cystic fibrosis (CF), caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, is the most common inherited life-limiting disease in North European people affecting 90,000 people worldwide. Progressive lung damage caused by recurrent infection and chronic airway inflammation is the major determinant of survival with a median age at death of 29 years. Approximately 60% of CF patients are infected with Aspergillus fumigatus, a ubiquitous environmental fungus, and its presence has been associated with accelerated lung function decline. Half of the patients infected with Aspergillus are <18 years of age. Yet, time of acquisition of this fungus and determinants of CF-related Aspergillus disease severity and progression are not known. CFTR expression has been demonstrated in cells of the innate and adaptive immune system and has shown to be critical for normal function. Research delineating the role of CFTR-deficient phagocytes in Aspergillus persistence and infection in the CF lung, has only recently received attention. In this concise review we aim to present the current understanding with respect to when people with CF acquire infection with A. fumigatus and antifungal immune responses by CF immune cells.

KW - aspergillosis

KW - aspergillus fumigatus

KW - cystic fibrosis

KW - colonisation

KW - innate immunity

KW - colonization

KW - Aspergillus fumigatus

UR - http://www.scopus.com/inward/record.url?scp=85063791085&partnerID=8YFLogxK

U2 - 10.1093/mmy/myy074

DO - 10.1093/mmy/myy074

M3 - Review article

VL - 57

SP - S118-S126

JO - Medical Mycology

JF - Medical Mycology

SN - 1369-3786

IS - Suppl. 2

ER -